Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;29(3):471-478.
doi: 10.1111/1744-9987.70012. Epub 2025 Mar 24.

Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates

Affiliations

Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates

Andrew Davenport. Ther Apher Dial. 2025 Jun.

Abstract

Introduction: Peritoneal solute transfer rates (PSTR) are reported to increase with time. Changes in PSTR were reviewed in long-term peritoneal dialysis (PD) patients to determine whether lower glucose degradation products (low GDP) dialysates prevented an increase in PSTR.

Methods: PSTR was determined with a 4-h peritoneal equilibrium test with a 2.0 L 22.7 g/L glucose dialysate.

Results: One hundred twenty-three PD patients treated for ≥4 years, 47.2% male, age 61 ± 16 years, 31.7% diabetic. Initially, 15.6% were treated with low GDP dialysates, which rose to 44.7% at 6 years. Creatinine PSTR increased with standard glucose dialysates (0.72 ± 0.1 at Year 3 to 0.79 ± 0.1 Year 5 and 0.82 ± 0.1 Year 6, p < 0.05), whereas PSTR was stable and lower with low GDP dialysates (0.71 ± 0.1, 0.65 ± 0.1, 0.68 ± 0.1); p < 0.001 for Years 5 and 6.

Conclusion: Exposure to standard glucose dialysates resulted in faster peritoneal solute transfer rates over time, whereas peritoneal solute transfer rates appeared more stable with lower glucose degradation products dialysates.

Keywords: bioimpedance; end stage kidney disease; glucose degradation products; icodextrin; peritoneal dialysis; peritoneal solute transport rate.

PubMed Disclaimer

Conflict of interest statement

The author has any conflicts of interest or competing interests.

Figures

FIGURE 1
FIGURE 1
The 4‐h effluent dialysate to plasma serum creatinine (D4h D/P Creat) after a 4‐h 2.0 L 22.7 g/L comparing the result for the first assessment of peritoneal membrane function (peritoneal equilibrium test [PET]) over time. Median with interquartile and 10%–90% ranges. ***p < 0.001 vs. first PET. GDP, glucose degradation products.
FIGURE 2
FIGURE 2
The 4‐h effluent dialysate to plasma serum sodium (D4h D/P Na) after a 4‐h 2.0 L 22.7 g/L exchange comparing the results for the first assessment of peritoneal membrane function (peritoneal equilibrium test [PET]) over time. Median with interquartile and 10%–90% ranges. ***p < 0.001 vs. first PET. GDP, glucose degradation products.

Similar articles

References

    1. Elphick E, Holmes M, Tabinor M, Cho Y, Nguyen T, Harris T, et al. Outcome measures for technique survival reported in peritoneal dialysis: a systematic review. Perit Dial Int. 2022;42(3):279–287. - PubMed
    1. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003;(84):S158–S161. 10.1046/j.1523-1755.63.s84.46 - DOI - PubMed
    1. Öberg CM. Optimization of bimodal automated peritoneal dialysis prescription using the three‐pore model. Perit Dial Int. 2021;41(4):381–393. - PubMed
    1. Piccapane F, Gerbino A, Carmosino M, Milano S, Arduini A, Debellis L, et al. Aquaporin‐1 facilitates Transmesothelial water permeability: in vitro and ex vivo evidence and possible implications in peritoneal dialysis. Int J Mol Sci. 2021;22(22):12535. - PMC - PubMed
    1. Helman J, Wahlgren H, Andersson L, Morelle J, Öberg CM. Quantifying ultrafiltration in peritoneal dialysis using the sodium dip. Kidney360. 2024;5(2):195–204. - PMC - PubMed